These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35425564)
1. Delivery of an immunogenic cell death-inducing copper complex to cancer stem cells using polymeric nanoparticles. Passeri G; Northcote-Smith J; Suntharalingam K RSC Adv; 2022 Feb; 12(9):5290-5299. PubMed ID: 35425564 [TBL] [Abstract][Full Text] [Related]
2. A reactive oxygen species-generating, cancer stem cell-potent manganese(ii) complex and its encapsulation into polymeric nanoparticles. Eskandari A; Suntharalingam K Chem Sci; 2019 Sep; 10(33):7792-7800. PubMed ID: 31588328 [TBL] [Abstract][Full Text] [Related]
3. The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles. Eskandari A; Boodram JN; Cressey PB; Lu C; Bruno PM; Hemann MT; Suntharalingam K Dalton Trans; 2016 Nov; 45(44):17867-17873. PubMed ID: 27774561 [TBL] [Abstract][Full Text] [Related]
4. Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex. Kaur P; Johnson A; Northcote-Smith J; Lu C; Suntharalingam K Chembiochem; 2020 Dec; 21(24):3618-3624. PubMed ID: 32776422 [TBL] [Abstract][Full Text] [Related]
5. Encapsulation and Delivery of an Osteosarcoma Stem Cell Active Gallium(III)-Diflunisal Complex Using Polymeric Micelles. Passeri G; Vincent RA; Xiao Z; Northcote-Smith J; Suntharalingam K ChemMedChem; 2023 Feb; 18(4):e202200599. PubMed ID: 36533570 [TBL] [Abstract][Full Text] [Related]
7. The Anti-Breast Cancer Stem Cell Potency of Copper(I)-Non-Steroidal Anti-Inflammatory Drug Complexes. Johnson A; Feng X; Singh K; Ortu F; Suntharalingam K Molecules; 2023 Sep; 28(17):. PubMed ID: 37687229 [TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell and Bulk Cancer Cell Active Copper(II) Complexes with Vanillin Schiff Base Derivatives and Naproxen. Lu C; Eskandari A; Cressey PB; Suntharalingam K Chemistry; 2017 Aug; 23(47):11366-11374. PubMed ID: 28658520 [TBL] [Abstract][Full Text] [Related]
9. Modulating the Chemical and Biological Properties of Cancer Stem Cell-Potent Copper(II)-Nonsteroidal Anti-Inflammatory Drug Complexes. Shin J; Eskandari A; Suntharalingam K Molecules; 2019 Apr; 24(9):. PubMed ID: 31035718 [TBL] [Abstract][Full Text] [Related]
10. A Copper(II) Phenanthroline Metallopeptide That Targets and Disrupts Mitochondrial Function in Breast Cancer Stem Cells. Laws K; Bineva-Todd G; Eskandari A; Lu C; O'Reilly N; Suntharalingam K Angew Chem Int Ed Engl; 2018 Jan; 57(1):287-291. PubMed ID: 29144008 [TBL] [Abstract][Full Text] [Related]
11. The Anti-Cancer Stem Cell Properties of Copper(II)-Terpyridine Complexes with Attached Salicylaldehyde Moieties. Singh K; Northcote-Smith J; Feng X; Singh K; Suntharalingam K Chembiochem; 2024 Oct; ():e202400703. PubMed ID: 39401178 [TBL] [Abstract][Full Text] [Related]
12. Induction of Necroptosis in Cancer Stem Cells using a Nickel(II)-Dithiocarbamate Phenanthroline Complex. Flamme M; Cressey PB; Lu C; Bruno PM; Eskandari A; Hemann MT; Hogarth G; Suntharalingam K Chemistry; 2017 Jul; 23(40):9674-9682. PubMed ID: 28556445 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-mediated specific elimination of soft cancer stem cells by targeting low cell stiffness. Chen X; Fan Y; Sun J; Zhang Z; Xin Y; Li K; Tang K; Du P; Liu Y; Wang G; Yang M; Tan Y Acta Biomater; 2021 Nov; 135():493-505. PubMed ID: 34492369 [TBL] [Abstract][Full Text] [Related]
14. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells. Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270 [TBL] [Abstract][Full Text] [Related]
15. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells. Zhang Z; Deng Q; Xiao C; Li Z; Yang X Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133 [TBL] [Abstract][Full Text] [Related]
16. Polypyridyl Zinc(II)-Indomethacin Complexes with Potent Anti-Breast Cancer Stem Cell Activity. Rundstadler TK; Eskandari A; Norman SM; Suntharalingam K Molecules; 2018 Sep; 23(9):. PubMed ID: 30181492 [TBL] [Abstract][Full Text] [Related]
18. A reactive oxygen species-generating, cyclooxygenase-2 inhibiting, cancer stem cell-potent tetranuclear copper(ii) cluster. Lu C; Laws K; Eskandari A; Suntharalingam K Dalton Trans; 2017 Oct; 46(38):12785-12789. PubMed ID: 28932846 [TBL] [Abstract][Full Text] [Related]
19. 4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis. Yi T; Kabha E; Papadopoulos E; Wagner G Oncotarget; 2014 Aug; 5(15):6028-37. PubMed ID: 25115391 [TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes. Boodram JN; Mcgregor IJ; Bruno PM; Cressey PB; Hemann MT; Suntharalingam K Angew Chem Int Ed Engl; 2016 Feb; 55(8):2845-50. PubMed ID: 26806362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]